Specifically, scRNA-Seq analysis of the CD45+ immune population in GBM showed this population as expressing gene signatures reflective of both immune activation and immune suppression, that, in sum, demonstrate and provide evidence of the complex heterogeneity of the myeloid compartment that might be dependent upon the location within the TME. This evidence concerns the gene PTPRC and glioblastoma.